Skip to main content
. 2019 Nov 1;112(5):498–506. doi: 10.1093/jnci/djz173

Figure 1.

Figure 1.

Oncologist and practice characteristics and frequency of discussions about costs of genomic testing and related treatment. A) By types of tumors treated (P < .001); (B) By training in genomic testing (P = .001); (C) by use of next-generation sequencing (NGS) gene panel tests (P < .001); (D) by whether practice has electronic medical records (EMR) with alerts for genomic tests (P < .001). Pearson χ2 test was used to calculate the P values. All statistical tested were two-sided.